Nuvation Bio Inc. (NYSE:NUVB) is one of the Stocks to Buy Under $10 with High Potential. On January 15, Soumit Roy from JonesTrading reiterated a Buy rating on the stock and raised the price target ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nura Bio, Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of ...
We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. Nuvation Bio Inc. stands seventh on our list among the best oncology stocks. TheFly reported on January 12 that H.C. Wainwright ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation ...
The MarketWatch News Department was not involved in the creation of this content. Targeting the Root Causes of Aging Demonstrates Powerful Anti-Cancer Activity Across Multiple Tumor Models MIAMI BEACH ...
Climb Bio appointed Dr. Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr.
Instil Bio stock falls after the company ends development of its lead cancer drug and exits a licensing deal, raising new questions about its pipeline and next steps.
INmune Bio Inc. (NASDAQ:INMB) stock surged by 24.72% in after-hours trading on Friday. The company announced a novel selective soluble TNF inhibitor, which is likely to have influenced the stock’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback